Evidence map›Paper›PMID 21967817›Full record

ArticleThe American journal of pathology2011

Neuroglobin is an endogenous neuroprotectant for retinal ganglion cells against glaucomatous damage.

Xin Wei, Zhanyang Yu, Kin-Sang Cho, Huihui Chen, Muhammad Taimur A Malik, Xiaoming Chen, Eng H Lo, Xiaoying Wang, Dong F Chen

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Neuroinflammation in Primary Open-Angle Glaucoma.Journal of clinical medicine · 2020
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Neuroglobin, a Factor Playing for Nerve Cell Survival.International journal of molecular sciences · 2016
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Xin WeiSchepens Eye Research Institute, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts 02114, USA.
Zhanyang Yu
Kin-Sang Cho
Huihui Chen
Muhammad Taimur A Malik
Xiaoming Chen
Eng H Lo
Xiaoying Wang
Dong F Chen
Massachusetts Eye and Ear Infirmary · USMassachusetts General Hospital · USSichuan University · CN

Funding

Neuroprotective Mechanisms of Neuroglobin in StrokeR01NS049476 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI WANG, XIAOYING · 2006 to 2010
$1.7M
Functional Restoration of the Optic Nerve After Disease or DamageR01EY017641 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI CHEN, DONG FENG · 2008 to 2010
$1.5M
Glial Modulation of Cortical Development and Drug of Abuse-induced Brain DamageR21DA024803 · NIDA · SCHEPENS EYE RESEARCH INSTITUTE · PI CHEN, DONG FENG · 2009 to 2010
$529k
Biological Inquiry into the Mechanisms and Neuroprotective Strategy for TBII01RX000110 · VA · VA BOSTON HEALTH CARE SYSTEM · PI CHEN, DONG FENG · 2009 to 2014
–
NEI NIH HHS R01 EY017641NEI NIH HHS R01EY017641NIDA NIH HHS R21 DA024803NIDA NIH HHS R21DA024803NINDS NIH HHS R01 NS049476NINDS NIH HHS R01NS49476RRD VA I01 RX000110
6 · The paper itself

Abstract

Neuroglobin (NGB), a newly discovered member of the globin superfamily, may regulate neuronal survival under hypoxia or oxidative stress. Although NGB is greatly expressed in retinal neurons, the biological functions of NGB in retinal diseases remain largely unknown. We investigated the role of NGB in an experimental model of glaucoma, a neurodegenerative disorder that usually involves elevation of intraocular pressure (IOP). Elevated IOP is thought to induce oxidative stress in retinal ganglion cells (RGCs), thereby causing RGC death and, eventually, blindness. We found that NGB plays a critical role in increasing RGC resistance to ocular hypertension and glaucomatous damage. Elevation of IOP stimulated a transient up-regulation of endogenous NGB in RGCs. Constitutive overexpression of NGB in transgenic mice prevented RGC damage induced by glutamate cytotoxicity in vitro and/or by chronic IOP elevation in vivo. Moreover, overexpression of NGB attenuated ocular hypertension-induced superoxide production and the associated decrease in ATP levels in mice, suggesting that NGB acts as an endogenous neuroprotectant to reduce oxidative stress and improve mitochondrial function, thereby promoting RGC survival. Thus, NGB may modulate RGC susceptibility to glaucomatous neural damage. Manipulating the expression and bioactivity of NGB may represent a novel therapeutic strategy for glaucoma.

Indexed as

AnimalsCells, CulturedGlaucomaGlobinsIntraocular PressureMiceMice, Inbred C57BLMice, TransgenicMitochondrial DiseasesNerve Tissue ProteinsNeuroglobinOxidative StressReactive Oxygen SpeciesRetinal Ganglion CellsSuperoxidesGlobinsNerve Tissue ProteinsNeuroglobinReactive Oxygen SpeciesSuperoxides

Identifiers

PMID21967817
PMCPMC3260831
OpenAlexW2102354682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.